Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

Roche, Summit Cancer Centers to collaborate on use of new digital healthcare tools to enable more personalized cancer care

PR Newswire July 13, 2020

New Data From Phase IIIb Study Reinforces Safety Profile of Genentech's Hemlibra (emicizumab-kxwh) in People With Hemophilia A

Business Wire July 13, 2020

Genentech Provides Update on Phase III Study of Tecentriq in Women With Advanced-stage Ovarian Cancer

Business Wire July 13, 2020

Spark Therapeutics Announces Updated Data on SPK-8011 from Phase 1/2 Clinical Trial in Hemophilia A at ISTH 2020 Virtual Congress

GlobeNewswire July 12, 2020

FDA Approves Genentech's Phesgo (Fixed-dose Combination of Perjeta and Herceptin for Subcutaneous Injection) for HER2-positive Breast Cancer

Business Wire June 29, 2020

Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles

Livemoney June 24, 2020

Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma

PR Newswire June 19, 2020

Genentech's IPATential150 Study Evaluating Ipatasertib in Combination With Abiraterone and Prednisone/Prednisolone Met One of Its Co-Primary Endpoints

Business Wire June 19, 2020

Genentech's Tecentriq in Combination With Chemotherapy (including Abraxane) Meets Primary Endpoint of Improved Pathological Complete Response, Regardless of PD-L1 Status, as Initial Treatment for People With Early Triple-negative Breast Cancer

Business Wire June 18, 2020

SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests

Business Wire June 16, 2020

Positive Phase III Results for Venclexta Combination in Acute Myeloid Leukemia Presented At EHA 2020

Business Wire June 13, 2020

Genentech Announces 2-Year Risdiplam Data From SUNFISH and New Data From JEWELFISH in Infants, Children and Adults With Spinal Muscular Atrophy (SMA)

Business Wire June 12, 2020

COVID-19: An additional contribution to the testing landscape in Canada

Canada NewsWire June 9, 2020

FDA Approves Genentech's Tecentriq in Combination With Avastin for People With the Most Common Form of Liver Cancer

Business Wire May 29, 2020

Genentech Initiates Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients With Severe COVID-19 Pneumonia

Business Wire May 28, 2020

Port Delivery System With Ranibizumab Shows Positive Phase III Results in Neovascular Age-Related Macular Degeneration

Business Wire May 27, 2020

New Longer-Term Data Reinforce Safety of Genentech's Satralizumab in Adults and Adolescents With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Business Wire May 22, 2020

Roche highly accurate antibody test for COVID-19 goes live at more than 20 initial lab sites in the US

PR Newswire May 19, 2020

Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases

PR Newswire May 19, 2020

FDA Approves Genentech's Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung Cancer

Business Wire May 18, 2020